Significance of D-dimer in Assessment of Severity and Mortality of COVID-19 Patients A Tertiary Care Hospital Study
Abstract
Keywords
Full Text:
PDFReferences
Bosevski M, Krstevski G, Bosevska G, et al. (2021). The role of D-dimer in relation to the clinical course of patients with COVID-19. Acta Biochim Biophys Sin (Shanghai), 53(1), 119-120.
Ghaith, M. M., Albanghali, M. A., Aldairi, A. F., Iqbal, M. S., Almaimani, R. A., Alquthami, K., … Almasmoum, H. A. (2021). Potential Predictors of Poor Prognosis among Severe COVID-19 Patients: A Single-Center Study. Canadian Journal of Infectious Diseases and Medical Microbiology, 2021. https://doi.org/10.1155/2021/6656092.
Hadid T, Kafri Z, Al-Katib A. (2021). Coagulation and anticoagulation in COVID-19. Blood Rev, 47, 100761. DOI: 10.1016/j.blre.2020.100761
Halaby R, Popma CJ, Cohen A, Chi G, Zacarkim MR, Romero G, et al. (2015). D-dimer elevation and adverse outcomes. J Thromb Thrombolysis, 39(1), 55–9. DOI: 10.1007/s11239-014-1101-6
Liu, J., Liu, Y., Xiang, P., Pu, L., Xiong, H., Li, C. & Wang, X. (2020). Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. Journal of Translational Medicine, 18(206). DOI: 10.1186/s12967-020-02374-0
Mattiuzzi C, Lippi G. (2020). Which lessons shall we learn from the 2019 novel coronavirus outbreak? Ann Transl Med, 8, 48.
Poudel A, Poudel Y, Adhikari A, Aryal BB, Dangol D, et al. (2021) D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19. Plos One, 16(8), e0256744. https://doi.org/10.1371/journal.pone.0256744
Shah S, Shah K, Patel SB, Patel FS, Osman M, Velagapudi P, Turagam MK, Lakkireddy D, Garg J. (2020). Elevated D-dimer levels are associated with increased risk of mortality in coronavirus disease 2019: A Systematic Review and Meta-Analysis. Cardiol Rev, 28(6), 295-302.
Soni M, Gopalakrishnan R, Vaishya R, Prabu P. (2020). D-dimer level is a useful predictor for mortality in patients with COVID-19: Analysis of 483 cases. Diabetes Metab Syndr Clin Res Rev, 14, 2245–2249. pmid:33395786
Valerio L, Ferrazzi P, Sacco C, Ruf W, Kucher N, Konstantinides S V., et al. (2021). Course of D-dimer and C-Reactive Protein Levels in Survivors and Nonsurvivors with COVID-19 Pneumonia: A Retrospective Analysis of 577 Patients. Thromb Haemost, 121(1), 98–101.DOI: 10.1055/s-0040-1721317
Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, et al. (2020). D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care, 8, 49. pmid:32665858
Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. (2020). D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost, 18, 1324–1329. pmid:32306492
Zheng J. (2020). SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat. Int J Biol Sci, 16(10), 1678-85. doi: 10.7150/ijbs.45053
Zhou F, Yu T, Du R, et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 395, 1054–1062
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 395, 1054–1062.
Refbacks
- There are currently no refbacks.